Skip to main content
OpenTrials

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

834 public trials 155 recruiting studies
Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

Study of REGN4461, a Leptin Receptor Agonist Antibody, in Patients With Generalized Lipodystrophy

NCT04159415

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Generalized Lipodystrophy, Genetic Diseases, Inborn, +10 more
Locations
  • Regeneron Research Site Bethesda, Maryland, United States
  • Regeneron Research Site Ann Arbor, Michigan, United States
  • Regeneron Research Site Dallas, Texas, United States
  • Regeneron Research Site Piura, Peru
View Trial Details
Completed

Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)

NCT05089084

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +9 more
Locations
  • Clinical Site 1 Boca Raton, Florida, United States
  • Clinical Site 2 Suwanee, Georgia, United States
  • Clinical Site 3 Indianapolis, Indiana, United States
  • Clinical Site 4 Elkridge, Maryland, United States
View all 58 locations
View Trial Details
Completed

A Gene Therapy Study in Patients With Gaucher Disease Type 1

NCT05324943

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Kaiser Permanente Los Angeles, California, United States
  • Lysosomal Rare Disorders Research and Treatment Center Fairfax, Virginia, United States
  • Hospital de Clinicas de Porto Alegre (HCPA) Porto Alegre, Brazil
  • SphinCS Höchheim, Germany
View Trial Details
Completed

Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

NCT03614234

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
Locations
  • UAB Medicine Birmingham, Alabama, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • University of Iowa Hospitals and Clinica Iowa City, Iowa, United States
  • Infusion Associates Grand Rapids, Michigan, United States
View all 14 locations
View Trial Details
Completed

Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZ-3102 in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease

NCT05758922

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +22 more
Locations
  • Hospital Pequeno Principe Curitiba, Brazil
  • Hospital de Clinicas de Porto Alegre Porto Alegre, Brazil
  • Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira Rio de Janeiro, Brazil
View Trial Details
Completed

Prevalence of Fabry's Disease in a Population of Patients With Chronic Pain

NCT02450604

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +25 more
Locations
  • Cs douleur chronique GHSR, CHU Sud Réunion Saint-Pierre, La Réunion, France
  • CeRCa, Unité de Neuromyologie, CHU de Fort de France FORT de France, Martinique, France
  • Centre Douleurs Chroniques, CH de la Côte Basque Bayonne, France
  • Centre Douleurs Chroniques, CHU de Bordeaux Bordeaux, France
View all 21 locations
View Trial Details

Related conditions